Arabian International Healthcare Holding Company

TADAWUL:9530.SR

34 (SAR) • At close July 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) SAR.

202420232022202120202019
Revenue 814.425806.924642.7618.54818.689697.033
Cost of Revenue 634.416616.886488.5475.021620.309525.689
Gross Profit 180.009190.038154.2143.518198.38171.344
Gross Profit Ratio 0.2210.2360.240.2320.2420.246
Reseach & Development Expenses 000000
General & Administrative Expenses 018.15112.6679.5529.9158.924
Selling & Marketing Expenses 019.24314.6449.40610.2459.25
SG&A 150.81637.393109.118.95820.1618.174
Other Expenses 0112.5772.82672.00379.972.296
Operating Expenses 150.816149.971109.190.96100.0690.47
Operating Income 29.19340.06745.174.571110.22282.346
Operating Income Ratio 0.0360.050.070.1210.1350.118
Total Other Income Expenses Net -84.52213.855-23.971-13.369-22.72-25.618
Income Before Tax -55.32953.92234.593.738119.7956.729
Income Before Tax Ratio -0.0680.0670.0540.1520.1460.081
Income Tax Expense 9.64711.57410.911.4242415.6
Net Income -66.61338.08820.47482.31495.7941.129
Net Income Ratio -0.0820.0470.0320.1330.1170.059
EPS -3.371.921.294.124.792.06
EPS Diluted -3.371.921.024.124.792.06
EBITDA 8.415111.10665.111106.446147.64690.235
EBITDA Ratio 0.010.1380.1010.1720.180.129